Laurent Pharmaceuticals Receives Health Canada’s Approval to Initiate COVID-19 Clinical Trial

Company to test LAU-7b’s dual pro-resolving inflammation and antiviral properties against COVID-19

Read More

Committed to developing treatments
for orphan diseases

Laurent Pharmaceuticals is an orphan drug company with a clinical development program in cystic fibrosis.  


laurent Lauren2 Laurent3

Cystic Fibrosis

       Science

LAU-7B

Events

Laurent Pharmaceuticals to participate at NACFC 2019, in Nashville TN, October 31st - November 2nd 2019

Laurent Pharmaceuticals to participate at  BIO2019, in Philadelphia PA, June 3-6 2019

 

News

Laurent Pharmaceuticals Joins Battle Against COVID-19

Read more  

Laurent Pharmaceuticals Receives a CAD 2.7M Financing from BioMed Propulsion Fund

Read more